Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Glatiramer acetate: A complex drug beyond biologics.

Rocco P, Eberini I, Musazzi UM, Franzè S, Minghetti P.

Eur J Pharm Sci. 2019 May 15;133:8-14. doi: 10.1016/j.ejps.2019.03.011. Epub 2019 Mar 19.

2.

What if? Mouse proteomics after gene inactivation.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Laurenzi T, Parravicini C, Eberini I.

J Proteomics. 2019 May 15;199:102-122. doi: 10.1016/j.jprot.2019.03.008. Epub 2019 Mar 13. Review.

PMID:
30876943
3.

Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs.

Dell'Omo G, Crescenti D, Vantaggiato C, Parravicini C, Borroni AP, Rizzi N, Garofalo M, Pinto A, Recordati C, Scanziani E, Bassi FD, Pruneri G, Conti P, Eberini I, Maggi A, Ciana P.

Br J Cancer. 2019 Mar;120(5):537-546. doi: 10.1038/s41416-018-0372-7. Epub 2019 Feb 11.

PMID:
30739913
4.

Strategic single point mutation yields a solvent- and salt-stable transaminase from Virgibacillus sp. in soluble form.

Guidi B, Planchestainer M, Contente ML, Laurenzi T, Eberini I, Gourlay LJ, Romano D, Paradisi F, Molinari F.

Sci Rep. 2018 Nov 6;8(1):16441. doi: 10.1038/s41598-018-34434-3.

5.

Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand.

Knebel C, Kebben J, Eberini I, Palazzolo L, Hammer HS, Süssmuth RD, Heise T, Hessel-Pras S, Lampen A, Braeuning A, Marx-Stoelting P.

Arch Toxicol. 2018 Dec;92(12):3471-3486. doi: 10.1007/s00204-018-2321-x. Epub 2018 Oct 6.

6.

In silico Description of LAT1 Transport Mechanism at an Atomistic Level.

Palazzolo L, Parravicini C, Laurenzi T, Guerrini U, Indiveri C, Gianazza E, Eberini I.

Front Chem. 2018 Aug 24;6:350. doi: 10.3389/fchem.2018.00350. eCollection 2018.

7.

Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.

Lauria S, Perrotta C, Casati S, Di Renzo I, Ottria R, Eberini I, Palazzolo L, Parravicini C, Ciuffreda P.

Bioorg Med Chem. 2018 May 15;26(9):2561-2572. doi: 10.1016/j.bmc.2018.04.024. Epub 2018 Apr 12.

PMID:
29678535
8.

Editorial: A matter of ingredients.

Miller I, Gianazza E, Eberini I.

J Proteomics. 2018 Apr 30;178:1-6. doi: 10.1016/j.jprot.2018.03.019. Epub 2018 Mar 24. No abstract available.

PMID:
29581062
9.

Body composition and metabolic changes during a 520-day mission simulation to Mars.

Strollo F, Macchi C, Eberini I, Masini MA, Botta M, Vassilieva G, Nichiporuk I, Monici M, Santucci D, Celotti F, Magni P, Ruscica M.

J Endocrinol Invest. 2018 Nov;41(11):1267-1273. doi: 10.1007/s40618-018-0861-9. Epub 2018 Mar 12.

10.

Bacterial Production, Characterization and Protein Modeling of a Novel Monofuctional Isoform of FAD Synthase in Humans: An Emergency Protein?

Leone P, Galluccio M, Barbiroli A, Eberini I, Tolomeo M, Vrenna F, Gianazza E, Iametti S, Bonomi F, Indiveri C, Barile M.

Molecules. 2018 Jan 6;23(1). pii: E116. doi: 10.3390/molecules23010116.

11.

Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening.

Platonova N, Parravicini C, Sensi C, Paoli A, Colombo M, Neri A, Eberini I, Chiaramonte R.

PLoS One. 2017 Nov 3;12(11):e0182640. doi: 10.1371/journal.pone.0182640. eCollection 2017.

12.

Gender proteomics I. Which proteins in non-sexual organs.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2018 Apr 30;178:7-17. doi: 10.1016/j.jprot.2017.10.002. Epub 2017 Oct 6.

PMID:
28988882
13.

Gender proteomics II. Which proteins in sexual organs.

Gianazza E, Miller I, Guerrini U, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2018 Apr 30;178:18-30. doi: 10.1016/j.jprot.2017.10.001. Epub 2017 Oct 6.

PMID:
28988880
14.

Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells.

Chiricozzi E, Pomè DY, Maggioni M, Di Biase E, Parravicini C, Palazzolo L, Loberto N, Eberini I, Sonnino S.

J Neurochem. 2017 Dec;143(6):645-659. doi: 10.1111/jnc.14146. Epub 2017 Sep 13.

15.

Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs.

Napolitano L, Scalise M, Koyioni M, Koutentis P, Catto M, Eberini I, Parravicini C, Palazzolo L, Pisani L, Galluccio M, Console L, Carotti A, Indiveri C.

Biochem Pharmacol. 2017 Nov 1;143:39-52. doi: 10.1016/j.bcp.2017.07.006. Epub 2017 Jul 12.

PMID:
28709952
16.

The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity.

Buoso E, Galasso M, Ronfani M, Papale A, Galbiati V, Eberini I, Marinovich M, Racchi M, Corsini E.

Toxicol Appl Pharmacol. 2017 Jun 15;325:37-47. doi: 10.1016/j.taap.2017.04.011. Epub 2017 Apr 13.

PMID:
28412309
17.

Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.

Napolitano L, Galluccio M, Scalise M, Parravicini C, Palazzolo L, Eberini I, Indiveri C.

Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):727-736. doi: 10.1016/j.bbagen.2017.01.013. Epub 2017 Jan 11.

18.

With or without you - Proteomics with or without major plasma/serum proteins.

Gianazza E, Miller I, Palazzolo L, Parravicini C, Eberini I.

J Proteomics. 2016 May 17;140:62-80. doi: 10.1016/j.jprot.2016.04.002. Epub 2016 Apr 10. Review.

19.

A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights.

Parravicini C, Daniele S, Palazzolo L, Trincavelli ML, Martini C, Zaratin P, Primi R, Coppolino G, Gianazza E, Abbracchio MP, Eberini I.

Cell Signal. 2016 Jun;28(6):631-42. doi: 10.1016/j.cellsig.2016.03.001. Epub 2016 Mar 10.

PMID:
26971834
20.

Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity.

Contente ML, Serra I, Palazzolo L, Parravicini C, Gianazza E, Eberini I, Pinto A, Guidi B, Molinari F, Romano D.

Org Biomol Chem. 2016 Apr 7;14(13):3404-8. doi: 10.1039/c6ob00047a. Epub 2016 Mar 8.

21.

Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex.

Stanic J, Carta M, Eberini I, Pelucchi S, Marcello E, Genazzani AA, Racca C, Mulle C, Di Luca M, Gardoni F.

Nat Commun. 2015 Dec 18;6:10181. doi: 10.1038/ncomms10181.

22.

In silico prediction and characterization of protein post-translational modifications.

Gianazza E, Parravicini C, Primi R, Miller I, Eberini I.

J Proteomics. 2016 Feb 16;134:65-75. doi: 10.1016/j.jprot.2015.09.026. Epub 2015 Oct 9.

PMID:
26436211
23.

Stereoselective reduction of aromatic ketones by a new ketoreductase from Pichia glucozyma.

Contente ML, Serra I, Brambilla M, Eberini I, Gianazza E, De Vitis V, Molinari F, Zambelli P, Romano D.

Appl Microbiol Biotechnol. 2016 Jan;100(1):193-201. doi: 10.1007/s00253-015-6961-y. Epub 2015 Sep 16.

PMID:
26377422
24.

Human FAD synthase is a bi-functional enzyme with a FAD hydrolase activity in the molybdopterin binding domain.

Giancaspero TA, Galluccio M, Miccolis A, Leone P, Eberini I, Iametti S, Indiveri C, Barile M.

Biochem Biophys Res Commun. 2015 Sep 25;465(3):443-9. doi: 10.1016/j.bbrc.2015.08.035. Epub 2015 Aug 12.

PMID:
26277395
25.

All-Purpose Containers? Lipid-Binding Protein - Drug Interactions.

Beringhelli T, Gianazza E, Maggioni D, Scanu S, Parravicini C, Sensi C, Monaco HL, Eberini I.

PLoS One. 2015 Jul 13;10(7):e0132096. doi: 10.1371/journal.pone.0132096. eCollection 2015.

26.

Oxysterols act as promiscuous ligands of class-A GPCRs: in silico molecular modeling and in vitro validation.

Sensi C, Daniele S, Parravicini C, Zappelli E, Russo V, Trincavelli ML, Martini C, Abbracchio MP, Eberini I.

Cell Signal. 2014 Dec;26(12):2614-20. doi: 10.1016/j.cellsig.2014.08.003. Epub 2014 Aug 22.

PMID:
25152366
27.

A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites.

Galli CL, Sensi C, Fumagalli A, Parravicini C, Marinovich M, Eberini I.

PLoS One. 2014 Aug 11;9(8):e104822. doi: 10.1371/journal.pone.0104822. eCollection 2014.

28.

In vitro chronic administration of ERbeta selective ligands and prostate cancer cell growth: hypotheses on the selective role of 3beta-adiol in AR-positive RV1 cells.

Colciago A, Ruscica M, Mornati O, Piccolella M, Montagnani-Marelli M, Eberini I, Festuccia C, Magni P, Motta M, Negri-Cesi P.

Biomed Res Int. 2014;2014:801473. doi: 10.1155/2014/801473. Epub 2014 Apr 29.

29.

In between - Proteomics of dog biological fluids.

Miller I, Preßlmayer-Hartler A, Wait R, Hummel K, Sensi C, Eberini I, Razzazi-Fazeli E, Gianazza E.

J Proteomics. 2014 Jun 25;106:30-45. doi: 10.1016/j.jprot.2014.04.016. Epub 2014 Apr 22. Review.

PMID:
24768907
30.

Recombinant S. cerevisiae expressing Old Yellow Enzymes from non-conventional yeasts: an easy system for selective reduction of activated alkenes.

Romano D, Contente ML, Molinari F, Eberini I, Ruvutuso E, Sensi C, Amaretti A, Rossi M, Raimondi S.

Microb Cell Fact. 2014 Apr 25;13:60. doi: 10.1186/1475-2859-13-60.

31.

Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays.

Sensi C, Simonelli S, Zanotti I, Tedeschi G, Lusardi G, Franceschini G, Calabresi L, Eberini I.

PLoS One. 2014 Apr 15;9(4):e95044. doi: 10.1371/journal.pone.0095044. eCollection 2014.

32.

Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling.

Pochini L, Seidita A, Sensi C, Scalise M, Eberini I, Indiveri C.

Biochem Pharmacol. 2014 Jun 1;89(3):422-30. doi: 10.1016/j.bcp.2014.03.014. Epub 2014 Apr 1.

PMID:
24704252
33.

Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformatics.

Tonazzi A, Eberini I, Indiveri C.

PLoS One. 2013 Dec 9;8(12):e82286. doi: 10.1371/journal.pone.0082286. eCollection 2013.

34.

Unfolding of beta-lactoglobulin on the surface of polystyrene nanoparticles: experimental and computational approaches.

Miriani M, Eberini I, Iametti S, Ferranti P, Sensi C, Bonomi F.

Proteins. 2014 Jul;82(7):1272-82. doi: 10.1002/prot.24493. Epub 2014 Jan 15.

PMID:
24338946
35.

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils.

Raccosta L, Fontana R, Maggioni D, Lanterna C, Villablanca EJ, Paniccia A, Musumeci A, Chiricozzi E, Trincavelli ML, Daniele S, Martini C, Gustafsson JA, Doglioni C, Feo SG, Leiva A, Ciampa MG, Mauri L, Sensi C, Prinetti A, Eberini I, Mora JR, Bordignon C, Steffensen KR, Sonnino S, Sozzani S, Traversari C, Russo V.

J Exp Med. 2013 Aug 26;210(9):1711-28. doi: 10.1084/jem.20130440. Epub 2013 Jul 29.

36.

C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.

Sciarretta S, Marchitti S, Bianchi F, Moyes A, Barbato E, Di Castro S, Stanzione R, Cotugno M, Castello L, Calvieri C, Eberini I, Sadoshima J, Hobbs AJ, Volpe M, Rubattu S.

Circ Res. 2013 May 10;112(10):1355-64. doi: 10.1161/CIRCRESAHA.113.301325. Epub 2013 Mar 25.

PMID:
23529183
37.

A proteomic portrait of atherosclerosis.

Eberini I, Wait R, Calabresi L, Sensi C, Miller I, Gianazza E.

J Proteomics. 2013 Apr 26;82:92-112. doi: 10.1016/j.jprot.2013.02.007. Epub 2013 Feb 19. Review.

PMID:
23435058
38.

Inflammatory serum proteome pattern in mice fed a high-fat diet.

Gianazza E, Sensi C, Eberini I, Gilardi F, Giudici M, Crestani M.

Amino Acids. 2013 Mar;44(3):1001-8. doi: 10.1007/s00726-012-1433-5. Epub 2012 Dec 6.

PMID:
23224824
39.

Biosynthesis of flavin cofactors in man: implications in health and disease.

Barile M, Giancaspero TA, Brizio C, Panebianco C, Indiveri C, Galluccio M, Vergani L, Eberini I, Gianazza E.

Curr Pharm Des. 2013;19(14):2649-75. Review.

PMID:
23116402
40.

Wards in the keyway: amino acids with anomalous pK(a)s in calycins.

Eberini I, Sensi C, Bovi M, Molinari H, Galliano M, Bonomi F, Iametti S, Gianazza E.

Amino Acids. 2012 Dec;43(6):2457-68. doi: 10.1007/s00726-012-1324-9. Epub 2012 May 30.

PMID:
22643844
41.

Proteomics of rat biological fluids--the tenth anniversary update.

Gianazza E, Wait R, Eberini I, Sensi C, Sironi L, Miller I.

J Proteomics. 2012 Jun 18;75(11):3113-28. doi: 10.1016/j.jprot.2012.03.053. Epub 2012 Apr 6. Review.

PMID:
22504499
42.

In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date.

Barlow DJ, Buriani A, Ehrman T, Bosisio E, Eberini I, Hylands PJ.

J Ethnopharmacol. 2012 Apr 10;140(3):526-34. doi: 10.1016/j.jep.2012.01.041. Epub 2012 Feb 2. Review.

43.

Neglected markers: altered serum proteome in murine models of disease.

Gianazza E, Vegeto E, Eberini I, Sensi C, Miller I.

Proteomics. 2012 Feb;12(4-5):691-707. doi: 10.1002/pmic.201100320. Epub 2012 Jan 19. Review.

PMID:
22247026
44.

Class A GPCRs: a multifaceted reality.

Parravicini C, Sensi C, Eberini I.

Purinergic Signal. 2011 Sep;7(3):279-81. doi: 10.1007/s11302-011-9243-x. No abstract available.

45.

In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases.

Eberini I, Daniele S, Parravicini C, Sensi C, Trincavelli ML, Martini C, Abbracchio MP.

J Comput Aided Mol Des. 2011 Aug;25(8):743-52. doi: 10.1007/s10822-011-9455-8. Epub 2011 Jul 9.

PMID:
21744154
46.

Simulation of urea-induced protein unfolding: a lesson from bovine β-lactoglobulin.

Eberini I, Emerson A, Sensi C, Ragona L, Ricchiuto P, Pedretti A, Gianazza E, Tramontano A.

J Mol Graph Model. 2011 Sep;30:24-30. doi: 10.1016/j.jmgm.2011.06.004. Epub 2011 Jun 13.

PMID:
21724434
47.

Electrostatics of folded and unfolded bovine β-lactoglobulin.

Eberini I, Sensi C, Barbiroli A, Bonomi F, Iametti S, Galliano M, Gianazza E.

Amino Acids. 2012 May;42(5):2019-30. doi: 10.1007/s00726-011-0933-z. Epub 2011 May 26.

PMID:
21614557
48.

Energy matters: mitochondrial proteomics for biomedicine.

Gianazza E, Eberini I, Sensi C, Barile M, Vergani L, Vanoni MA.

Proteomics. 2011 Feb;11(4):657-74. doi: 10.1002/pmic.201000412. Epub 2011 Jan 17. Review.

PMID:
21241019
49.

Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.

Rocco AG, Sensi C, Gianazza E, Calabresi L, Franceschini G, Sirtori CR, Eberini I.

J Mol Graph Model. 2010 Nov;29(3):406-14. doi: 10.1016/j.jmgm.2010.08.002. Epub 2010 Aug 20.

PMID:
20869895
50.

Other than IPG-DALT: 2-DE variants.

Miller I, Eberini I, Gianazza E.

Proteomics. 2010 Feb;10(4):586-610. doi: 10.1002/pmic.200900451. Review.

PMID:
19834911

Supplemental Content

Loading ...
Support Center